These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 34857909
21. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Wiesner T, Kutzner H, Cerroni L, Mihm MC, Busam KJ, Murali R. Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384 [Abstract] [Full Text] [Related]
22. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. Marušić Z, Buljan M, Busam KJ. J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915 [Abstract] [Full Text] [Related]
23. Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) Conundrum: PRKAR1A Inactivation Can Occur in Different Genetic Backgrounds (Common, Blue, and Spitz Subgroups) With Variation in Their Clinicopathologic Characteristics. de la Fouchardiere A, Tirode F, Castillo C, Buisson A, Boivin F, Macagno N, Pissaloux D. Am J Surg Pathol; 2022 Aug 01; 46(8):1106-1115. PubMed ID: 35319526 [Abstract] [Full Text] [Related]
24. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy. Soares de Sá BC, de Macedo MP, Torrezan GT, Braga JCT, Fidalgo F, Moredo LF, Lellis R, Duprat JP, Carraro DM. BMC Cancer; 2019 Nov 09; 19(1):1077. PubMed ID: 31706282 [Abstract] [Full Text] [Related]
25. A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis. Kastnerova L, Martinek P, Grossmann P, Steiner P, Vanecek T, Kyclova J, Ferak I, Zalud R, Slehobr O, Svajdler P, Sulc M, Bradamante M, Banik M, Hadravsky L, Sticova E, Hajkova V, Ptakova N, Michal M, Kazakov DV. Am J Dermatopathol; 2020 Aug 09; 42(8):578-592. PubMed ID: 32701692 [Abstract] [Full Text] [Related]
26. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Am J Dermatopathol; 2019 Mar 09; 41(3):167-179. PubMed ID: 30801340 [Abstract] [Full Text] [Related]
27. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome. Silva-Clavería F, Álvarez-Muñoz A, Ferrándiz L, Fernández-Orland A, Conde-Martin AF, Moreno-Ramírez D, Ríos-Martín JJ. Int J Surg Pathol; 2023 Oct 09; 31(7):1398-1402. PubMed ID: 36803128 [Abstract] [Full Text] [Related]
28. BAP1-inactivated melanocytic tumour with borderline histopathological features (BAP1-inactivated melanocytoma): A case report and a reappraisal. Ferrara G, Mariani MP, Auriemma M. Australas J Dermatol; 2021 Feb 09; 62(1):e88-e91. PubMed ID: 33107024 [Abstract] [Full Text] [Related]
33. Histopathologic clues for the diagnosis of Wiesner nevus. Llamas-Velasco M, Pérez-Gónzalez YC, Requena L, Kutzner H. J Am Acad Dermatol; 2014 Mar 09; 70(3):549-54. PubMed ID: 24373783 [Abstract] [Full Text] [Related]
35. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer. McDonnell KJ, Gallanis GT, Heller KA, Melas M, Idos GE, Culver JO, Martin SE, Peng DH, Gruber SB. Cancer Genet; 2016 Mar 09; 209(3):75-81. PubMed ID: 26774355 [Abstract] [Full Text] [Related]
38. CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate "Pigmented Epithelioid Melanocytoma," Expanding the Morphologic Spectrum of Blue Tumors: A Clinicopathologic Study of 7 Cases. Goto K, Pissaloux D, Paindavoine S, Tirode F, de la Fouchardière A. Am J Surg Pathol; 2019 Oct 09; 43(10):1368-1376. PubMed ID: 31162285 [Abstract] [Full Text] [Related]